Latest news with #Glycomet
India Today
5 days ago
- Business
- India Today
Meet Leena Gandhi Tewari, the SUV chairperson who bought India's costliest flats
Leena Gandhi Tewari is a name not many know well, but she recently caught everyone's attention after buying the most expensive flats in India. She bought two sea-facing luxury duplex apartments in Mumbai's Worli area for Rs 639 crore. This deal broke records and surprised many in the property and financial RECORD-BREAKING REAL ESTATE DEALSpanning over 22,572 sq ft, the duplex apartments are situated from the 32nd to the 35th floor in the 40-storey Naman Xana building on Worli Sea Face, overlooking the Arabian Sea. The price works out to more than Rs 2.83 lakh per sq the huge purchase amount, Leena paid over Rs 63.9 crore extra in stamp duty and taxes, making the total cost close to Rs 703 crore. This move was quiet but powerful, much like her OF USVLeena is the chairperson of USV, a Mumbai-based pharmaceutical company, which was started by her late father, Vithal Gandhi, in partnership with Revlon in 1961. Forbes estimates Leena's net worth at $3.9 billion, as of May 30, 2025, making her one of India's richest keeps her personal life as private as her business affairs. She is known to be a close friend of Nita Ambani. Her husband, Prashant Tewari, who is also involved with USV, is an IIT graduate and a mechanical engineer from Cornell. Their daughter, Aneesha Gandhi Tewari, holds a Ph.D. in molecular biology from MIT and was appointed to USV's board in August popular medicines, such as Glycomet for diabetes and Ecosprin for blood thinning, enjoy wide recognition and trust across the Leena Tewari's record property purchase and her leadership of USV demonstrate her influence both in business and beyond.
Time of India
5 days ago
- Business
- Time of India
Who is Leena Tewari? Owner of India's costliest flats worth over Rs 700 crore, spanning 22,572 sq ft in Worli
Leena Tewari , the chairperson of Mumbai-based USV Pharmaceuticals , recently captured public attention for buying India's most expensive residential property—a pair of sea-facing luxury duplex apartments in Worli, Mumbai, for a staggering Rs 639 crore. She also paid Rs 63.9 crore stamp duty and GST. That's nearly Rs 703 crore in total. The landmark deal This landmark deal, reported by The Economic Times on May 28, set a new record in the Indian real estate market with a price exceeding Rs 2.83 lakh per sq ft on a carpet basis, covering 22,572 sq ft across the 32nd to 35th floors of a premium 40-storey tower overlooking the Arabian Sea. She paid over Rs 63.9 crore towards stamp duty and the Goods & Services Tax alone for the registration of the transaction. After accounting for these charges, she has paid a total of nearly Rs 703 crore for the deals. Though widely known among patients for USV's flagship medicines such as Glycomet (for diabetes), Ecosprin (a blood thinner), and Roseday (for cholesterol), Leena Tewari herself maintains a notably low profile. Leena Tewari's net worth Forbes estimates her net worth at $3.9 billion, placing her among India's richest women. Despite her immense wealth, she has kept a discreet presence in business and social circles. Live Events Tewari is also a close friend of Nita Ambani , a prominent figure in Indian business and philanthropy. USV: Leena Tewari's family-run company Under Tewari's leadership, USV remains a family-run company, steadfastly resisting pressures to sell out, bring in private equity, or go public. USV reported revenues of Rs 4,840 crore in FY24, driven by its stronghold on the Indian pharmaceutical market, especially in the diabetes segment. Glycomet ranks as the second-leading anti-diabetes drug in India, just behind GSK's Augmentin. The company's other brands like Ecosprin and Roseday also command significant market shares. Looking ahead, USV faces growing competition from new generation diabetes drugs. To maintain its edge, the company is focusing on expanding its insulin portfolio in India and developing generic versions of blockbuster weight-loss drugs such as Ozempic and Wegovy.
Economic Times
5 days ago
- Business
- Economic Times
Leena Tiwari: Meet the reclusive billionaire owner of India's costliest flats
Mumbai: Glycomet, Ecosprin and Roseday are medicine brands familiar to millions of patients of diabetes or heart condition in India. But not much is known about Leena Tewari, the reclusive chairperson of USV, the Mumbai-based drugmaker that sells those drugs, among many name bounced into news and social circles after she purchased two sea-facing luxury duplex apartments in Mumbai's upscale Worli area for a whopping Rs 639 crore, making it the country's costliest residential property. ET broke the news online on the evening of May transaction shook the property market observers, financial circles, and public at large as it set a record for the most expensive deal concluded in India ever. At over Rs 2.83 lakh per sq ft on carpet basis, the record-breaking deal involves a total area of 22,572 sq ft, spanning the 32nd to 35th floors of a 40-storey super-premium tower overlooking the Arabian Sea on Worli Sea Face. That's not all. Tewari paid over Rs 63.9 crore towards stamp duty and the Goods & Services Tax alone for the registration of the transaction. After accounting for these charges, she has paid a total of nearly Rs 703 crore for the stealth move to buy the plush property resonates remarkably with her demeanour. Few may even know that Leena Tewari is among the closest friends of Nita Ambani. Her husband Prashant Tewari, MD at USV, has a similar temperament and is mostly seen as a quiet and long-term strategic thinker. She is among India's richest women, with Forbes estimating her current net worth at $3.9 decades, the family-run company has braved fierce competition while many of its peers sold out or took on board private equity players to grow their business, or even went for a public listing to raise USV has remained owner-driven and grown its revenues to Rs 4,840 crore in FY24, according to data from Tracxn. Industry executives say Leena Tewari shows no rush and prefers a step-wise approach than stray into risky zones. "She has a core team of 10-12 loyal USV executives to oversee the operations. She has a good sense of timing and does not follow hype," a veteran executive told ET. Her singular focus can be seen from the value of USV's top brands. The anti-diabetes drug Glycomet, for instance, is the second leading product in the Indian pharmaceutical market with sales of Rs 806 crore, ranking next to antibiotic drug Augmentin of GSK, which grossed sales of Rs 820 crore over the last twelve-month period. In blood thinners, USV's Ecosprin and its variants commands a dominant position while Roseday is another popular brand to lower cholesterol in heart patients. But, challenges loom for the future. Glycomet is seeing increasing rivalry from new generation anti-diabetes drugs. USV is looking at a strong position in the insulin business in India. Sources say the company is also keen to develop copies of semaglutide, the material that goes into blockbuster weight-loss brands Ozempic and Wegovy. ( Originally published on May 29, 2025 )
Time of India
5 days ago
- Business
- Time of India
Leena Tiwari: Meet the reclusive billionaire owner of India's costliest flats
Live Events (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel Mumbai: Glycomet , Ecosprin and Roseday are medicine brands familiar to millions of patients of diabetes or heart condition in India. But not much is known about Leena Tewari , the reclusive chairperson of USV , the Mumbai-based drugmaker that sells those drugs, among many name bounced into news and social circles after she purchased two sea-facing luxury duplex apartments in Mumbai's upscale Worli area for a whopping '639 crore, making it the country's costliest residential broke the news online on the evening of May transaction shook the property market observers, financial circles, and public at large as it set a record for the most expensive deal concluded in India over '2.83 lakh per sq ft on carpet basis, the record-breaking deal involves a total area of 22,572 sq ft, spanning the 32nd to 35th floors of a 40-storey super-premium tower overlooking the Arabian Sea on Worli Sea not all. Tewari paid over '63.9 crore towards stamp duty and the Goods & Services Tax alone for the registration of the transaction. After accounting for these charges, she has paid a total of nearly '703 crore for the stealth move to buy the plush property resonates remarkably with her demeanour. Few may even know that Leena Tewari is among the closest friends of Nita Ambani. Her husband Prashant Tewari, MD at USV, has a similar temperament and is mostly seen as a quiet and long-term strategic thinker. She is among India's richest women, with Forbes estimating her current net worth at $3.9 decades, the family-run company has braved fierce competition while many of its peers sold out or took on board private equity players to grow their business, or even went for a public listing to raise USV has remained owner-driven and grown its revenues to '4,840 crore in FY24, according to data from Tracxn. Industry executives say Leena Tewari shows no rush and prefers a step-wise approach than stray into risky zones. "She has a core team of 10-12 loyal USV executives to oversee the operations. She has a good sense of timing and does not follow hype," a veteran executive told singular focus can be seen from the value of USV's top brands. The anti-diabetes drug Glycomet, for instance, is the second leading product in the Indian pharmaceutical market with sales of '806 crore, ranking next to antibiotic drug Augmentin of GSK, which grossed sales of '820 crore over the last twelve-month period. In blood thinners, USV's Ecosprin and its variants commands a dominant position while Roseday is another popular brand to lower cholesterol in heart challenges loom for the future. Glycomet is seeing increasing rivalry from new generation anti-diabetes drugs. USV is looking at a strong position in the insulin business in India. Sources say the company is also keen to develop copies of semaglutide, the material that goes into blockbuster weight-loss brands Ozempic and Wegovy.
